Shiferman Gregory L. has filed 18 insider transactions across 2 companies since November 2024.
Most recent transaction: a grant/award of 50000 shares of Voyager Therapeutics, Inc. ($VYGR) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Voyager Therapeutics, Inc. | $VYGR | Shiferman Gregory L. | SVP and General Counsel | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 58,691,136 | 9999.99% | 0.09% |
| Jan. 6, 2026 | Voyager Therapeutics, Inc. | $VYGR | Shiferman Gregory L. | SVP and General Counsel | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 58,803,015 | 9999.99% | 0.17% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | D | Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.02% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | D | Stock Option (Right to Buy) | 28000 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.04% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | U | Common Stock | 7215 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.01% |
| July 31, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | D | Common Stock | 23735 | $0.00 | 0.0000 | 62,784,397 | 100.00% | 0.04% |
| June 24, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 79 | $9.22 | 30,950.0000 | 61,480,947 | 0.25% | 0.00% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 176 | $6.91 | 31,029.0000 | 61,480,947 | 0.56% | 0.00% |
| April 10, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | A | Common Stock | 525 | $0.00 | 31,205.0000 | 61,480,947 | 1.71% | 0.00% |
| March 24, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 79 | $8.21 | 30,680.0000 | 61,480,947 | 0.26% | 0.00% |
| Feb. 24, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 2502 | $7.49 | 30,759.0000 | 61,480,947 | 7.52% | 0.00% |
| Feb. 13, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 376 | $7.18 | 33,512.0000 | 61,480,947 | 1.11% | 0.00% |
| Feb. 13, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 251 | $7.18 | 33,261.0000 | 61,480,947 | 0.75% | 0.00% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | A | Stock Option (Right to buy) | 28000 | $0.00 | 28,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2025 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | A | Common Stock | 14000 | $0.00 | 33,888.0000 | 0 | 70.39% | 0.00% |
| Dec. 24, 2024 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | F | Common Stock | 79 | $5.48 | 19,888.0000 | 0 | 0.40% | 0.00% |
| Nov. 1, 2024 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | A | Common Stock | 5000 | $0.00 | 19,967.0000 | 0 | 33.41% | 0.00% |
| Nov. 1, 2024 | Sage Therapeutics, Inc. | $SAGE | Shiferman Gregory L. | See Remarks | A | Stock Option (Right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |